AllDocs -> cancers

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:xDrGFSwRwEwJ:www.friedlicorp.com/pdfs/05.03.01MyriadPressRelease.pdf allintitle: brain cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

Contact: William A. Hockett Vice President of Corporate Communications (801) 584-3600 Email: bhockett@myriad.com www.myriad.com FOR IMMEDIATE RELEASE Myriad Initiates Phase 1 Trial of MPC-6827 in Metastatic Brain Cancer -Preclinical Data to be Presented at AACR Conference - Salt Lake City, March 1, 2005 -Myriad Genetics, Inc. (Nasdaq: MYGN), announced today that it will begin a second Phase I clinical trial with its investigative cancer drug, MPC-6827, under an FDA-approved Investigational New Drug application. This new human clinical study will evaluate the potential of MPC-6827 to treat metastatic brain cancer by achieving therapeutic concentrations in the brain that are sufficient to treat tumors without significant systemic exposure or toxicity. The Phase 1 clinical study will be performed at Memorial Sloan-Kettering Cancer ...

Secondary brain cancer This factsheet is for those who have been diagnosed with secondary cancer in the brain that has spread from the breast. It describes what secondary brain cancer is, what the symptoms are and the treatments used. Being told that your cancer has spread to the brain can be particularly distressing and one of the common fears people have is of not knowing what effects this will have on their life. We hope this factsheet answers some of your questions and helps you to discuss your options with your specialist team. You may also find it helpful to read our Secondary breast cancer booklet, which looks at the physical and emotional impact of living with secondary breast cancer . What is secondary brain cancer ? Secondary brain cancer occurs when cancer cells from the breast spread through the lymph or blood system to ...

brain cancer Secondary cancer of the brain ? how to manage the symptoms Introduction This fact sheet has been prepared to provide information about symptoms associated with growth of secondary cancer in the brain . Structure and function of the brain The brain , together with the spinal cord, is the control centre which governs how the body functions. The basic cell of the brain is the nerve cell (neurone); you are born with the total number of nerve cells and, unlike other cells, they do not replace themselves as they die. The nerve cells communicate with each other and other parts of the body by sending messages along the nerve pathways or by controlling the release of hormones. The brain is a large organ enclosed within layers of membranes, the meninges, which contain fluid (cerebrospinal fluid). The brain and its coverings fit closely inside the rigid skull and there is not much room for ...

brain cancer FINDING DIFFERENTIALLY EXPRESSED GENES IN GLIOBLATOMA MULTIFORME (A TYPE OF BRAIN CANCER ) BY CLUSTERING VIDYADHARI EDUPUGANTI CSE 591 DATA MINING 04/24/03 PROBLEM STATEMENT A Glioblastoma is a type of a primary brain tumor Primary brain tumors can either be benign or malignant Malignant brain tumors, such as glioblastomas tend to grow rapidly spreading into the surrounding brain tissue with the help of proliferating core and invasive rim cells which cannot be entirely removed surgically. The proliferate and invasive nature of glioma cells is perhaps the key feature in their persistence beyond therapeutic margins and is the primary reason for tumor recurrence and malignant progression Continued Different methods have been introduced for the evaluation of glioma migration(proliferation ...

statistics Brain Cancer Source: PENN State - Graduate Student Research Statistics: PA Department of health, Bureau of Health Statistics ( 2001, August) Analysis of cancer incidence in PA counties 1994-1998 1999 Brain Cancer Statistics (Ages 15 and above) Tri County Area Cases per 100,000 Montgomery County 73 10.08 Berks County 35 9.77 Chester County 22 5.12 1999 (Ages 15 and above) Montgomery County has the HIGHEST RATE of brain cancer by a large margin compared to: U.S., PA, and Tioga County in PA ( a less polluted county for comparison) Brain Cancer in Montgomery County (1995 to 1999) almost DOUBLED in only 5 years Montgomery County Brain Cancer 1995 5.80 per 100,000 1999 10.08 per 100,000 1999 Brain Cancer Statistics - Pottstown Brain Cancer Rate per 100,000 in Pottstown - 9.25 ¯ This is SIGNIFICANTLY ...

Researchers Search for Causes of Brain Cancer National Brain Tumor Foundation sponsors groundbreaking international research consortium in search for causes of brain tumors. San Francisco, CA (PRWEB) February 19, 2005 -- Cell phones, power lines, and diet have all been investigated as possible causes of brain tumors yet definitive answers continue to elude scientists. Each year, the public interest in wanting to know the causes of cancer grow yet research has been slow in finding answers. As a way of increasing our understanding of brain tumors and focusing more attention on causes, the National Brain Tumor Foundation is supporting a new international consortium of brain tumor researchers who hope to combine forces to better answers the question “What Causes Brain Tumors?” The purpose of this group, named the BTEC or the Brain Tumor Epidemiology Consortium, is to develop multi-center ...

H E in vivo t ra n s fer and ex p ression of fo reign ge n e s into malignant brain tumor cells rep resents a new t h e rapeutic ap p ro a ch for these incurable neoplasms. P revious attempts at gene tra n s fer into malignant bra i n t u m o rs have focused on the use of rep l i c at i o n - d e fi c i e n t re t rov i ruses in animal models, 3 , 6 , 8 , 1 2 , 1 4 , 1 6 as well as in an o n going clinical tri a l . 1 3 R e t rov i ruses have the adva n t age of s e l e c t ive integration into rep l i c ating cells, but their use is limited by low titer of the ve c t o r- p roducer cells, va ri abl e ex p ression of the ge n e, and the possibility of insert i o n a l mu t agenesis. Herpes simplex ve c t o rs have also been used for gene tra n s fer into the central nervous system (CNS), 1 , 7 but their poor transduction effi c i e n cy and potential neuro- ...

Primary brain and other central nervous system (CNS) cancers made up 1.4 percent of the incident (newly diagnosed) cancers reported to the Ohio Cancer Incidence Surveillance System (OCISS) for the years 1997 through 2001 (Table 1). Primary tu- mors, or those tumors that originate in the brain or CNS, serve as the focus of this report. The average annual age-adjusted brain and other CNS cancer incidence rate during this time period was 6.8 cases per 100,000 residents (an average of 784 cases per year). Average annual numbers and rates represent the number of cases diagnosed per year on average, not the total number of cases diagnosed during the five-year time period. The average annual age-adjusted U.S. (SEER 1 ) incidence rate for 1997-2001 was 6.4 cases per 100,000 residents, which is about 6 percent less than the rate for Ohio. Completeness of reporting of brain and ...

B R E A S T C A N C E R C A R E K I L N H O U S E , 2 1 0 N E W K I N G S R O A D , L O N D O N S W 6 4 N Z . T E L : 0 2 0 7 3 8 4 2 9 8 4 H E L P L I N E 0 8 0 8 8 0 0 6 0 0 0 W E B S I T E W W W . B R E A S T C A N C E R C A R E . O R G . U K R E G I S T E R E D I N E N G L A N D C O M P A N Y N O . 2 4 4 7 1 8 2 . R E G I S T E R E D C H A R I T Y N O . 1 0 1 7 6 5 8 Secondary brain cancer February 2005 This factsheet is for those who have been diagnosed with secondary cancer in the brain that has spread from the breast. It describes what secondary brain cancer is, what the symptoms are and the treatments used. Being told that your cancer has spread to the brain can be particularly distressing and one of the common fears people have is of not knowing what effects this will have on their life. We hope this factsheet answers some of your questions and helps ...

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:3LTS95IbkU0J:walther.org/wcf_blogs/WCFFriendsForLife/MarchApril_2004__italics_Friends_for_Life_stopitalics_/FFL_MarApr04_Newsletter.pdf allintitle: brain cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare ...

Imaging Endogenous Gene Expression in Brain Cancer In Vivo with 111 In-Peptide Nucleic Acid Antisense Radiopharmaceuticals and Brain Drug-Targeting Technology Toyofumi Suzuki, PhD 1 ; Dafang Wu, MD, PhD 2 ; Felix Schlachetzki, MD 3 ; Jian Yi Li, MD, PhD 4 ; Ruben J. Boado, PhD 4 ; and William M. Pardridge, MD 4 1 College of Pharmacy, Nihon University, Chiba, Japan; 2 Department of Radiology, Wayne State University, Detroit, Michigan; 3 Department of Neurology, Regensburg University, Regensburg, Germany; and 4 Department of Medicine, UCLA, Los Angeles, California Imaging endogenous gene expression with sequence-specific antisense radiopharmaceuticals is possible if the antisense agent is enabled to traverse the ...

[ CANCER RESEARCH 63, 5821–5828, September 15, 2003] Identification of a Cancer Stem Cell in Human Brain Tumors Sheila K. Singh, Ian D. Clarke, Mizuhiko Terasaki, Victoria E. Bonn, Cynthia Hawkins, Jeremy Squire, and Peter B. Dirks The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada [S. K. S., I. D. C., M. T., V. E. B., P. B. D.], and Program in Developmental Biology [S. K. S., I. D. C., M. T., V. E. B., P. B. D.], Division of Neurosurgery [S. K. S., P. B. D.], Department of Pediatric Laboratory Medicine [C. H.], and Department of Laboratory Medicine and Pathobiology [J. S.], University of Toronto, Toronto, Ontario M5G 1X8 Canada ABSTRACT Most current research on human brain tumors is focused on the molecular and cellular analysis of the bulk tumor mass. However, there is overwhelming evidence in some ...

Sorting Out One of Cancer's Great Challenges: Brain Metastases Presented by nationally renowned Gamma Knife expert Douglas Kondziolka, MD, MS, FRCS (C), professor of neurological surgery and radiation oncology at the University of Pittsburgh Following Dr. Kondziolka's presentation, there will be a metro case conference, at which you can present potential Gamma Knife cases for review. *To participate in the metro case conference, physicians must send images on CD and patient history to Swedish Medical Center Cancer Registry by February 10th (799 E. Hampden Ave., Suite 100, Englewood, CO 80113). If radiology study was done at a HealthONE facility, physician needs to call 303-788-8348 with the following information: patient name, DOB, film study date, type of study, and location study was done. February 17, 2005 Inverness Hotel and Conference Center 200 ...

New Treatment for Brain Cancer Suggested lead: Researchers say they are encouraged by the results of early phase clinical trials of an experimental new treatment for brain cancer . Tom Britt has more. Cut 1SOQ:60 . ( Preview this in a WAV file in 16-bit mono. ) Researchers at the Duke Comprehensive Cancer Center have started testing a new method for killing cancerous brain tumor cells. It's a new class of drugs called "immunotoxins" -- consisting of a bacterial toxin that has been genetically altered and combined with a protein that makes the killer bacteria avoid normal cells and attack only the cancerous cells in the brain . Duke neurosurgeon Dr. John Sampson is the lead investigator in the study, which involves injecting the immunotoxin directly into the brain . "What we're able to do is basically percolate the drug through the brain using this micro-infusion technology." ...

“Speaking Freely” Proposed Cell Phone – Brain Cancer Public Re-Education Project SPOT 1: Public Service Message first rough concept storyboards april 1999 copyright imaginalia unltd. prepared for: Ed Herriman, PR chair, North American Cellular Communications Device Manufacturing Association (NACCDMA) Page 2 Notes. These boards were created under the assumption that Matthew Perry will be available. His agent did say he’s looking to do more of this kind of spot. If, however, he falls through, Paul Reiser would also work, or, possibly, Ray Romano. Jerry Seinfeld would also be nice but obviously prohibitively expensive for this kind of civic-minded project. Anyway. Properly executed, this approach will go a long way, as discussed, towards allaying widespread and constantly increasing ...

Identification of candidate cancer -causing genes in mouse brain tumors by retroviral tagging PNAS August 3, 2004 • Reporter: Tian Su • 23/01/2005 Page 2 AIM BACKGROUND EXPERIMENTAL PROCESS RESULT SUMMARY Page 3 AIM Develop a system allowing for the retroviral tagging of candidate genes in malignant brain tumors. Page 4 BACKGROUND Page 5 Background(1) Why retroviral tagging ? • R etroviral insertional mutagenesis in mice causes a high incidence of tumors • Proviral tagging is a powerful method to identify cancer -related genes in hematopoietic tumors. • Retroviral tagging has not yet been applicable to solid tumors ,except the mouse mammary tumor virus ...

Researchers Use Crippled Poliovirus to Attack Brain Cancer DURHAM, N.C. -- In a daring yet successful experiment to cure deadly brain tumors, researchers have combined the cancer -killing properties of poliovirus together with a harmless genetic coding element from the common cold. The resulting modified virus created a remarkably strong anti- cancer agent that rapidly killed cancer cells in laboratory cell cultures and in animals -- and without causing polio, said Matthias Gromeier, M.D., assistant professor of molecular genetics and microbiology at the Duke Comprehensive Cancer Center. Testing of the new viral agent in humans should begin within two years, he said. In the study, the modified poliovirus rapidly killed cancer cells derived from primary brain tumors as well as cells derived from breast and colon cancer metastases -- all within a matter of four to six hours. In ...

Experimental Brain Cancer Treatment Suggested lead: Scientists are conducting early research on a new treatment for brain cancer that could yield better results with fewer side effects. Tom Britt has more. Cut 1SOQ: 60 . ( Preview this in a WAV file in 16-bit mono. ) The human brain has a natural defense mechanism called the "blood barrier." It's a gate that allows blood into the brain while keeping poisons in the blood from getting through. Until now, this barrier has meant that patients undergoing treatment for brain cancer usually had a poor prognosis. Dr. John Sampson of Duke University Medical Center says there is an experimental new treatment that puts the cancer fighting toxins directly into the brain - behind the blood barrier. "What we've done is essentially put the drug behind the gate and now the gate works to our benefit, by keeping the drug in the brain ...

Annual cancer incidence and death rates per 100,000 South Australians by age, 1991-2001 Cancer site: Brain Males 0.0 10.0 20.0 30.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 100, 000 Incidence Mortality Females 0.0 5.0 10.0 15.0 20.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 1 00, 000 Incidence Mortality Both 0.0 10.0 20.0 30.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 100, 000 Incidence Mortality

Telephone 131120 for cancer information and support A GUIDE FOR PEOPLE WITH THESE TUMOURS, THEIR FAMILIES AND FRIENDS A GUIDE FOR PEOPLE WITH THESE TUMOURS, THEIR FAMILIES AND FRIENDS Brain Spinal Cord Brain and and Spinal Cord Tumours Tumours Page 2 Brain and Spinal Cord Tumours First published (as Brain Cancer ) 1995 This edition December 2003 Acknowledgments The Cancer Council thanks everyone who contributed to the development and revision of this booklet. Illustration on page 7 by Con Stamatis. The Cancer Council Victoria is an independent, volunteer-based charity whose mission is to lead, coordinate, implement and evaluate action to minimise the human cost of cancer for all Victorians. Many ...

5 Jul 2003 No. 55 H I G H L I G H T S MMR vaccine safety debate continues 3 Preradiation chemotherapy superior for paediatric brain cancer 5 CONTENTS Adderall vs SLI 381 for paediatric ADHD 4 ADHD treatment not associated with growth deficits in girls 10 Amodiaquine (intermittent) reduces malarial fevers, anaemia in infants 7 Amoxicillin/clavulanic acid in febrile neutropenia 6 Anaesthesia: which strategy worth it for day surgery in the UK? 8 Autoimmune disease: are vaccines a potential cause? 4 Azithromycin superior to cefixime in bacillary dysentery 5 Breast milk antidepressant exposure does not impair infants’weight gain 10 Cefadroxil vs linezolid in paediatric skin infections 5 Cefixime vs azithromycin in bacillary dysentery 5 Chemotherapy (preradiation) ...

Date Received: __ Approved by: Meeting Date: 1/13-14/05 Charge Code: 7471-23 National Cancer Institute Brain SPORE Meeting San Francisco, CA TRAVEL EXPENSE STATEMENT Full Name: Meeting Date: __1/13-14/05__ Address to which check should be mailed (Please print clearly.): Daytime Phone: __ E-mail: _ MEALS AND LODGING Date Meals & Incidental Expenses Lodging (including tax) 1/12 $__ ($38.25 max if TD) $ billed to master 1/13 $__ ($51.00 max if NTD) $ billed to master 1/14 $__ ($38.25 max if TD) $ TOTAL (1) $ (2) $ GROUND TRANSPORTATION EXPENSES (Shuttle, Bus, Parking, Tolls, Taxis) Date Items/Explanation Cost 1/12 $ 1/14 $ TOTAL (3) $ POV (Privately Owned Vehicle) Date ...

Division of Environmental Epidemiology & Occupational Health 410 Capitol Avenue MS#11EOH PO Box 340308 Hartford, CT 06134-0308 • Many of the cases initially suggested by the union were ruled out because they were not malignant brain tumors. Some were brain tumors that were either benign (non-cancerous) or were a metastasis from an- other type of tumor. The brain is a common site to which a malignant tumor (a metastasis), which be- gins in another part in the body, can spread. Only malignant brain tumors were considered part of the investigation. Benign brain tumors have different risk factors. • There were four cases of primary, malignant (cancerous) brain tumors confirmed among white male employees at the P&W North Haven facility during the period 1991-1999. Three of these were the same type. The four individuals with primary brain ...

The machinists union contacted the Connecticut Department of Public Health to assist them in evaluating a concern of their mem- bers and families regarding a cluster of brain cancer cases at the North Haven facility. Those who were concerned had developed a list of persons they suspected had brain cancer who had worked at the facility. Since the number of cases was consistent with a need for follow-up, the DPH conducted a formal investigation during the summer and fall of 2000. There were several purposes in conducting the study: • Confirm the diagnoses of these cases medically. If tumors were found, see if they were malignant brain tumors. • Determine if there were any other cases. • Determine whether there were more cases of brain cancer oc- curring in P&W employees than would be expected based on comparison with the overall population in Connecticut. ...

Vol. 7, No. 4 February 9, 2001 New USC neuro-oncologist seeks new ways to fight brain cancer The story seems apocryphal, she ad- mits. When Kathleen Squires was a little girl growing up overseas in places like Indonesia, she saw people around her with elephantiasis—enlarged, bulging legs due to lymphatic infection—and asked her dad why they suffered from the deforming condition. “They don’t have good medical care,” he explained. And so, though no one in her family worked in medicine, she decided she would be a doctor. Today, she is one of the newest medi- cal faculty members of the Keck School of Medicine of USC, focusing on infec- tious diseases. Specifically, Squires— visiting associate professor of medi- cine—treats patients with HIV and AIDS and performs research on drugs that might better help such patients. She also logs ...

Rachel's Environment & Health News #266 - Brain Cancer Is Rapidly Increasing December 31, 1991 Brain cancer is relatively rare, accounting for only 2% of all cancers, but it seems to be increasing rapidly in children and in people over 65 in the U.S. The latest figures from the National Cancer Institute indicate that brain cancer in the elderly (ages 75-84) is doubling every 9 years [1, pg. 1621; 2, pg. 635.] In 1991 in the U.S., an estimated 16,700 new cases of brain cancer were diagnosed and an estimated 11,500 deaths occurred. [3, pgs. I.15-I.16] The causes of brain cancer are unknown. Brain cancer is usually fatal; the average (median) time between diagnosis and death is about nine months. [1, pg. 1621.] The average survival rate after 5 years is 25%, but in people over 65 the 5-year survival rate is only 4%. [3, pg. I.16.] ...